This study provided new insight into CDCA gene family members in NPC, and the prognostic signature based on CDCA3, CDCA5, and CDCA8 may facilitate clinicians to identify more aggressive and immunosuppressive tumors and make more individually appropriate therapeutic decisions. The gene discussed is CDCA5; the disease is nasopharyngeal carcinoma.